nach oben

Erschienen in:

13.06.2017 | Invited Review

Surgical therapy of prostatitis: a systematic review

verfasst von: Dominik S. Schoeb, Daniel Schlager, Martin Boeker, Ulrich Wetterauer, Martin Schoenthaler, Thomas R. W. Herrmann, Arkadiusz Miernik

Erschienen in: World Journal of Urology | Ausgabe 11/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The clinical term “prostatitis” refers to a clinical syndrome defined by the following 4 distinct entities: acute bacterial prostatitis (category 1), chronic bacterial prostatitis (category 2), chronic prostatitis/chronic pelvic pain syndrome (category 3), and asymptomatic prostatitis (category 4) The etiology of the chronic forms is still not fully understood and choice of therapy is often debated. The objective of this systematic review is to collect evidence on the surgical treatment of the chronic form of prostatitis and to evaluate its clinical implication.

Methods

We performed a systematic literature search and identified 6683 relevant publications, of which 16 were included in the review.

Results

Transurethral prostate resection was performed in 110 patients; 78 patients (70%) were reported as “cured”, 16 patients (15%) as improved, and 16 patients (15%) as unchanged. Radical prostatectomy was performed in 21 patients; a full resolution of prostatitis related symptoms was reported for 20 patients (95%). No increased rates of complications or unusual complications were noted.

Conclusions

Surgical therapy of chronic bacterial prostatitis or chronic pelvic pain syndrome might be a viable option; however, since little evidence is currently available and no randomized controlled trials have been conducted, the presently available data does not provide a base for clinical decisions.

Nur mit Berechtigung zugänglich

Krieger JN, Nyberg L Jr, Nickel JC (1999) NIH consensus definition and classification of prostatitis. JAMA 282(3):236–237PubMedCrossRef

Krieger JN, Lee SW, Jeon J, Cheah PY, Liong ML, Riley DE (2008) Epidemiology of prostatitis. Int J Antimicrob Agents 31(Suppl 1):S85–S90. doi:10.1016/j.ijantimicag.2007.08.028 PubMedCrossRef

Yoon BI, Kim S, Han DS, Ha US, Lee SJ, Kim HW, Han CH, Cho YH (2012) Acute bacterial prostatitis: how to prevent and manage chronic infection? J Infect Chemother 18(4):444–450. doi:10.1007/s10156-011-0350-y PubMedCrossRef

Lee YS, Han CH, Kang SH, Lee SJ, Kim SW, Shin OR, Sim YC, Lee SJ, Cho YH (2005) Synergistic effect between catechin and ciprofloxacin on chronic bacterial prostatitis rat model. Int J Urol 12(4):383–389. doi:10.1111/j.1442-2042.2005.01052.x PubMedCrossRef

Schaeffer AJ, Datta NS, Fowler JE, Krieger JN, Litwin MS, Nadler RB, Nickel JC, Pontari MA, Shoskes DA, Zeitlin SI, Hart C, Chronic Prostatitis Collaborative Research N (2002) Overview summary statement. Diagnosis and management of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). Urology 60(6 Suppl):1–4PubMedCrossRef

Murphy AB, Macejko A, Taylor A, Nadler RB (2009) Chronic prostatitis: management strategies. Drugs 69(1):71–84. doi:10.2165/00003495-200969010-00005 PubMedCrossRef

Alexander RB, Propert KJ, Schaeffer AJ, Landis JR, Nickel JC, O’Leary MP, Pontari MA, McNaughton-Collins M, Shoskes DA, Comiter CV, Datta NS, Fowler JE, Nadler RB, Zeitlin SI, Knauss JS, Wang Y, Kusek JW, Nyberg LM, Litwin MS, Chronic Prostatitis Collaborative Research N (2004) Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial. Ann Intern Med 141(8):581–589PubMedCrossRef

Nickel JC, Downey J, Clark J, Casey RW, Pommerville PJ, Barkin J, Steinhoff G, Brock G, Patrick AB, Flax S, Goldfarb B, Palmer BW, Zadra J (2003) Levofloxacin for chronic prostatitis/chronic pelvic pain syndrome in men: a randomized placebo-controlled multicenter trial. Urology 62(4):614–617PubMedCrossRef

Cheah PY, Liong ML, Yuen KH, Teh CL, Khor T, Yang JR, Yap HW, Krieger JN (2003) Terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome: a randomized, placebo controlled trial. J Urol 169(2):592–596. doi:10.1097/01.ju.0000042927.45683.6c PubMedCrossRef

10.

Nickel JC, Krieger JN, McNaughton-Collins M, Anderson RU, Pontari M, Shoskes DA, Litwin MS, Alexander RB, White PC, Berger R, Nadler R, O’Leary M, Liong ML, Zeitlin S, Chuai S, Landis JR, Kusek JW, Nyberg LM, Schaeffer AJ, Chronic Prostatitis Collaborative Research N (2008) Alfuzosin and symptoms of chronic prostatitis-chronic pelvic pain syndrome. N Engl J Med 359(25):2663–2673. doi:10.1056/NEJMoa0803240 PubMedPubMedCentralCrossRef

11.

Nickel JC, Narayan P, McKay J, Doyle C (2004) Treatment of chronic prostatitis/chronic pelvic pain syndrome with tamsulosin: a randomized double blind trial. J Urol 171(4):1594–1597. doi:10.1097/01.ju.0000117811.40279.19 PubMedCrossRef

12.

Nickel JC, O’Leary MP, Lepor H, Caramelli KE, Thomas H, Hill LA, Hoel GE (2011) Silodosin for men with chronic prostatitis/chronic pelvic pain syndrome: results of a phase II multicenter, double-blind, placebo controlled study. J Urol 186(1):125–131. doi:10.1016/j.juro.2011.03.028 PubMedCrossRef

13.

Tugcu V, Tasci AI, Fazlioglu A, Gurbuz G, Ozbek E, Sahin S, Kurtulus F, Cek M (2007) A placebo-controlled comparison of the efficiency of triple- and monotherapy in category 3 B chronic pelvic pain syndrome (CPPS). Eur Urol 51(4):1113–1117. doi:10.1016/j.eururo.2006.09.036 PubMedCrossRef

14.

Bates SM, Hill VA, Anderson JB, Chapple CR, Spence R, Ryan C, Talbot MD (2007) A prospective, randomized, double-blind trial to evaluate the role of a short reducing course of oral corticosteroid therapy in the treatment of chronic prostatitis/chronic pelvic pain syndrome. BJU Int 99(2):355–359. doi:10.1111/j.1464-410X.2007.06667.x PubMedCrossRef

15.

Goldmeier D, Madden P, McKenna M, Tamm N (2005) Treatment of category 3A prostatitis with zafirlukast: a randomized controlled feasibility study. Int J STD AIDS 16(3):196–200. doi:10.1258/0956462053420239 PubMedCrossRef

16.

Nickel JC, Atkinson G, Krieger JN, Mills IW, Pontari M, Shoskes DA, Crook TJ (2012) Preliminary assessment of safety and efficacy in proof-of-concept, randomized clinical trial of tanezumab for chronic prostatitis/chronic pelvic pain syndrome. Urology 80(5):1105–1110. doi:10.1016/j.urology.2012.07.035 PubMedCrossRef

17.

Nickel JC, Pontari M, Moon T, Gittelman M, Malek G, Farrington J, Pearson J, Krupa D, Bach M, Drisko J, Rofecoxib Prostatitis Investigator T (2003) A randomized, placebo controlled, multicenter study to evaluate the safety and efficacy of rofecoxib in the treatment of chronic nonbacterial prostatitis. J Urol 169(4):1401–1405. doi:10.1097/01.ju.0000054983.45096.16 PubMedCrossRef

18.

Wagenlehner FM, Ballarini S, Naber KG (2014) Immunostimulation in chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): a one-year prospective, double-blind, placebo-controlled study. World J Urol 32(6):1595–1603. doi:10.1007/s00345-014-1247-z PubMedCrossRef

19.

Zhao WP, Zhang ZG, Li XD, Yu D, Rui XF, Li GH, Ding GQ (2009) Celecoxib reduces symptoms in men with difficult chronic pelvic pain syndrome (Category 3A). Braz J Med Biol Res 42(10):963–967PubMedCrossRef

20.

De Rose AF, Gallo F, Giglio M, Carmignani G (2004) Role of mepartricin in category 3 chronic nonbacterial prostatitis/chronic pelvic pain syndrome: a randomized prospective placebo-controlled trial. Urology 63(1):13–16PubMedCrossRef

21.

Nickel JC, Downey J, Pontari MA, Shoskes DA, Zeitlin SI (2004) A randomized placebo-controlled multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category 3A chronic nonbacterial prostatitis). BJU Int 93(7):991–995. doi:10.1111/j.1464-410X.2003.04766.x PubMedCrossRef

22.

Shoskes DA, Zeitlin SI, Shahed A, Rajfer J (1999) Quercetin in men with category 3 chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial. Urology 54(6):960–963PubMedCrossRef

23.

Wagenlehner FM, Schneider H, Ludwig M, Schnitker J, Brahler E, Weidner W (2009) A pollen extract (Cernilton) in patients with inflammatory chronic prostatitis-chronic pelvic pain syndrome: a multicentre, randomised, prospective, double-blind, placebo-controlled phase 3 study. Eur Urol 56(3):544–551. doi:10.1016/j.eururo.2009.05.046 PubMedCrossRef

24.

Aboumarzouk OM, Nelson RL (2012) Pregabalin for chronic prostatitis. Cochrane Database Syst Rev. doi:10.1002/14651858.CD009063.pub2

25.

Pontari MA, Krieger JN, Litwin MS, White PC, Anderson RU, McNaughton-Collins M, Nickel JC, Shoskes DA, Alexander RB, O’Leary M, Zeitlin S, Chuai S, Landis JR, Cen L, Propert KJ, Kusek JW, Nyberg LM Jr, Schaeffer AJ, Chronic Prostatitis Collaborative Research N (2010) Pregabalin for the treatment of men with chronic prostatitis/chronic pelvic pain syndrome: a randomized controlled trial. Arch Intern Med 170(17):1586–1593. doi:10.1001/archinternmed.2010.319 PubMedPubMedCentralCrossRef

26.

Nickel JC, Forrest JB, Tomera K, Hernandez-Graulau J, Moon TD, Schaeffer AJ, Krieger JN, Zeitlin SI, Evans RJ, Lama DJ, Neal DE Jr, Sant GR (2005) Pentosan polysulfate sodium therapy for men with chronic pelvic pain syndrome: a multicenter, randomized, placebo controlled study. J Urol 173(4):1252–1255. doi:10.1097/01.ju.0000159198.83103.01 PubMedCrossRef

27.

Nickel JC, Johnston B, Downey J, Barkin J, Pommerville P, Gregoire M, Ramsey E (2000) Pentosan polysulfate therapy for chronic nonbacterial prostatitis (chronic pelvic pain syndrome category 3A): a prospective multicenter clinical trial. Urology 56(3):413–417PubMedCrossRef

28.

Giubilei G, Mondaini N, Minervini A, Saieva C, Lapini A, Serni S, Bartoletti R, Carini M (2007) Physical activity of men with chronic prostatitis/chronic pelvic pain syndrome not satisfied with conventional treatments–could it represent a valid option? The physical activity and male pelvic pain trial: a double-blind, randomized study. J Urol 177(1):159–165. doi:10.1016/j.juro.2006.08.107 PubMedCrossRef

29.

Kessler TM, Mordasini L, Weisstanner C, Juni P, da Costa BR, Wiest R, Thalmann GN (2014) Sono-electro-magnetic therapy for treating chronic pelvic pain syndrome in men: a randomized, placebo-controlled, double-blind trial. PLoS One 9(12):e113368. doi:10.1371/journal.pone.0113368 PubMedPubMedCentralCrossRef

30.

Lee SH, Lee BC (2009) Electroacupuncture relieves pain in men with chronic prostatitis/chronic pelvic pain syndrome: three-arm randomized trial. Urology 73(5):1036–1041. doi:10.1016/j.urology.2008.10.047 PubMedCrossRef

31.

Zimmermann R, Cumpanas A, Miclea F, Janetschek G (2009) Extracorporeal shock wave therapy for the treatment of chronic pelvic pain syndrome in males: a randomised, double-blind, placebo-controlled study. Eur Urol 56(3):418–424. doi:10.1016/j.eururo.2009.03.043 PubMedCrossRef

32.

Magistro G, Wagenlehner FM, Grabe M, Weidner W, Stief CG, Nickel JC (2016) Contemporary management of chronic prostatitis/chronic pelvic pain syndrome. Eur Urol 69(2):286–297. doi:10.1016/j.eururo.2015.08.061 PubMedCrossRef

33.

Shoskes DA, Nickel JC, Kattan MW (2010) Phenotypically directed multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study using UPOINT. Urology 75(6):1249–1253. doi:10.1016/j.urology.2010.01.021 PubMedCrossRef

34.

Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2010) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 8(5):336–341. doi:10.1016/j.ijsu.2010.02.007 CrossRef

35.

Higgins JPT GSH (2011) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration. http://www.cochrane-handbook.org. Accessed 20 Dec 2016

36.

Sterne JA, Hernan MA, Reeves BC, Savovic J, Berkman ND, Viswanathan M, Henry D, Altman DG, Ansari MT, Boutron I, Carpenter JR, Chan AW, Churchill R, Deeks JJ, Hrobjartsson A, Kirkham J, Juni P, Loke YK, Pigott TD, Ramsay CR, Regidor D, Rothstein HR, Sandhu L, Santaguida PL, Schunemann HJ, Shea B, Shrier I, Tugwell P, Turner L, Valentine JC, Waddington H, Waters E, Wells GA, Whiting PF, Higgins JP (2016) ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 355:i4919. doi:10.1136/bmj.i4919 PubMedPubMedCentralCrossRef

37.

Sghjm EM (1982) Radical transurethral prostatic resection in the management of chronic bacterial prostatitis. J Urol 131:184A

38.

Barnes RW, Hadley HL, O’Donoghue EP (1982) Transurethral resection of the prostate for chronic bacterial prostatitis. Prostate 3(3):215–219PubMedCrossRef

39.

Tarfusser Vvo BZ, Folmerz P (1993) Endosurgical alternatives in the treatment of the chronic prostatitis syndrome: part II. The transurethral procedures. J Endourol 7(Suppl 1):S182–S182

40.

Kagawa M, Takeshita H, Moriyama S, Adachi A, Chiba K, Noro A (2014) IgG4-related prostatitis impairs objective urinary function as with benign prostate hyperplasia: a case report successfully treated with transurethral resection. Low Urin Tract Symptoms 6(3):187–189. doi:10.1111/luts.12060 PubMedCrossRef

41.

Decaestecker K, Oosterlinck W (2015) Transurethral resection of the prostate in recurrent acute bacterial prostatitis. Urol Int 94(4):442–444. doi:10.1159/000367667 PubMedCrossRef

42.

Smart CJ, Jenkins JD (1973) The role of transurethral prostatectomy in chronic prostatitis. Br J Urol 45(6):654–662PubMedCrossRef

43.

Pfau A (1991) The treatment of chronic bacterial prostatitis. Infection 19(Suppl 3):S160–S164PubMedCrossRef

44.

Frazier HA, Spalding TH, Paulson DF (1992) Total prostatoseminal vesiculectomy in the treatment of debilitating perineal pain. J Urol 148(2):409–411PubMedCrossRef

45.

Alexander RB (2003) Radical prostatectomy for chronic prostatitis. BJU Int 92(Suppl 3):e17PubMed

46.

Lai AKS (2011) Laparoscopic prostatectomy for severely symptomatic, treatment-refractory chronic prostatitis: preliminary observations from an ongoing phase II clinical trial. Urotoday Int J 4(2):30

47.

McLoughlin LC, McDermott TE, Thornhill JA (2014) Radical prostatectomy in the presence of ongoing refractory ESBL Escherichia coli bacterial prostatitis. BMJ Case Rep. doi:10.1136/bcr-2014-206291 PubMedPubMedCentral

48.

Chopra S, Satkunasivam R, Aron M (2016) Feasibility of robotic radical prostatectomy for medication refractory chronic prostatitis/chronic pelvic pain syndrome: initial results. Indian J Urol 32(3):238–241. doi:10.4103/0970-1591.185105 PubMedPubMedCentralCrossRef

49.

Wagenlehner FME, Naber KG, Bschleipfer T, Brähler E, Weidner W (2009) Prostatitis and male pelvic pain syndrome: diagnosis and treatment. Deutsches Arzteblatt 106(11):175–183

50.

Evans DT (1994) Treatment of chronic abacterial prostatitis: a review. Int J STD AIDS 5(3):157–164. doi:10.1177/095646249400500301 PubMedCrossRef

51.

Nickel JC (1999) Prostatitis: evolving management strategies. Urol Clin N Am 26(4):737. doi:10.1016/s0094-0143(05)70215-9 CrossRef

52.

Parker J, Buga S, Sarria JE, Spiess PE (2010) Advancements in the management of urologic chronic pelvic pain: what is new and what do we know? Curr Urol Rep 11(4):286–291PubMedCrossRef

53.

Krieger JN, Riley DE, Cheah PY, Liong ML, Yuen KH (2003) Epidemiology of prostatitis: new evidence for a world-wide problem. World J Urol 21(2):70–74. doi:10.1007/s00345-003-0329-0 PubMedCrossRef

54.

McNaughton Collins M, Pontari MA, O’Leary MP, Calhoun EA, Santanna J, Landis JR, Kusek JW, Litwin MS, Chronic Prostatitis Collaborative Research N (2001) Quality of life is impaired in men with chronic prostatitis: the Chronic Prostatitis Collaborative Research Network. J Gen Intern Med 16(10):656–662PubMedPubMedCentralCrossRef

55.

Calhoun EA, McNaughton Collins M, Pontari MA, O’Leary M, Leiby BE, Landis JR, Kusek JW, Litwin MS, Chronic Prostatitis Collaborative Research N (2004) The economic impact of chronic prostatitis. Arch Intern Med 164(11):1231–1236. doi:10.1001/archinte.164.11.1231 PubMedCrossRef

56.

Duloy AM, Calhoun EA, Clemens JQ (2007) Economic impact of chronic prostatitis. Curr Urol Rep 8(4):336–339PubMedCrossRef

57.

Litwin MS, McNaughton-Collins M, Fowler FJ Jr, Nickel JC, Calhoun EA, Pontari MA, Alexander RB, Farrar JT, O’Leary MP (1999) The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network. J Urol 162(2):369–375PubMedCrossRef

58.

Magri V, Marras E, Restelli A, Wagenlehner FM, Perletti G (2015) Multimodal therapy for category 3 chronic prostatitis/chronic pelvic pain syndrome in UPOINTS phenotyped patients. Exp Ther Med 9(3):658–666. doi:10.3892/etm.2014.2152 PubMedCrossRef

59.

Nickel JC, Siemens DR, Brenda J (1998) Transurethral radiofrequency hot balloon thermal therapy in chronic nonbacterial prostatitis. Tech Urol 4(3):128–130PubMed

60.

Hirasawa Y, Yoshioka K, Nasu Y, Yamamoto M, Hinotsu S, Takenaka A, Fujisawa M, Shiroki R, Tozawa K, Fukasawa S, Kashiwagi A, Tatsugami K, Tachibana M, Terachi T, Gotoh M, Japanese Society of E (2017) Impact of surgeon and hospital volume on the safety of robot-assisted radical prostatectomy: a multi-institutional study based on a national database. Urol Int. doi:10.1159/000460304 PubMed

61.

Nickel JC, True LD, Krieger JN, Berger RE, Boag AH, Young ID, Collabora NACP (2001) Consensus development of a histopathological classification system for chronic prostatic inflammation. BJU Int 87(9):797–805. doi:10.1046/j.1464-410x.2001.02193.x PubMedCrossRef

62.

Ahyai SA, Gilling P, Kaplan SA, Kuntz RM, Madersbacher S, Montorsi F, Speakman MJ, Stief CG (2010) Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur Urol 58(3):384–397. doi:10.1016/j.eururo.2010.06.005 PubMedCrossRef

Titel: Surgical therapy of prostatitis: a systematic review
verfasst von: Dominik S. Schoeb
Daniel Schlager
Martin Boeker
Ulrich Wetterauer
Martin Schoenthaler
Thomas R. W. Herrmann
Arkadiusz Miernik
Publikationsdatum: 13.06.2017
Verlag: Springer Berlin Heidelberg
Erschienen in: World Journal of Urology / Ausgabe 11/2017
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI: https://doi.org/10.1007/s00345-017-2054-0

Neu im Fachgebiet Urologie

25.04.2024 | Nierenkarzinom | Nachrichten

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Surgical therapy of prostatitis: a systematic review

Abstract

Purpose

Methods

Results

Conclusions

Neu im Fachgebiet Urologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Stufenschema weist Prostatakarzinom zuverlässig nach

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Update Urologie

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 11/2017

Dose dense MVAC prior to radical cystectomy: a real-world experience

Impact of laser fiber tip cleavage on power output for ureteroscopy and stone treatment

“Finding the needle in a haystack”: oncologic evaluation of patients treated for LUTS with holmium laser enucleation of the prostate (HoLEP) versus transurethral resection of the prostate (TURP)

The role of solifenacin, as monotherapy or combination with tamsulosin in ureteral stent-related symptoms: a systematic review and meta-analysis

Outcome from 5-year live surgical demonstrations in urinary stone treatment: are outcomes compromised?

Transrectal ultrasound guided prostate biopsy in the era of increasing fluoroquinolone resistance: prophylaxis with single-dose ertapenem

Neu im Fachgebiet Urologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Stufenschema weist Prostatakarzinom zuverlässig nach

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Update Urologie